Raloxifene Has No Efficacy in Reducing the High Bone Turnover and the Risk of Spontaneous Vertebral Fractures after Denosumab Discontinuation

by Elena Gonzalez-Rodriguez, Delphine Stoll, Olivier Lamy
Published 2018-01-01

Commentary to “Denosumab for bone health in prostate and breast cancer patients receiving endocrine therapy? A systematic review and a meta-analysis of randomized trials” (Galvano...

by Elena Gonzalez-Rodriguez, Bérengère Aubry-Rozier, Delphine Stoll, Khalil Zaman, Olivier Lamy
Published 2020-06-01

The Metabolic Benefits of Menopausal Hormone Therapy Are Not Mediated by Improved Nutritional Habits. The OsteoLaus Cohort

by Georgios E. Papadakis, Didier Hans, Elena Gonzalez Rodriguez, Peter Vollenweider, Gerard Waeber, Pedro Marques-Vidal, Olivier Lamy
Published 2019-08-01

The Effects of Time-Restricted Eating versus Standard Dietary Advice on Weight, Metabolic Health and the Consumption of Processed Food: A Pragmatic Randomised Controlled Trial in C...

by Nicholas Edward Phillips, Julie Mareschal, Nathalie Schwab, Emily N. C. Manoogian, Sylvie Borloz, Giada Ostinelli, Aude Gauthier-Jaques, Sylvie Umwali, Elena Gonzalez Rodriguez, Daniel Aeberli, Didier Hans, Satchidananda Panda, Nicolas Rodondi, Felix Naef, Tinh-Hai Collet
Published 2021-03-01